BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27807884)

  • 1. Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care.
    Simpkins SJ; Pinto-Sanchez MI; Moayyedi P; Bercik P; Morgan DG; Bolino C; Ford AC
    Aliment Pharmacol Ther; 2017 Jan; 45(1):91-99. PubMed ID: 27807884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.
    Cubiella J; Salve M; Díaz-Ondina M; Vega P; Alves MT; Iglesias F; Sánchez E; Macía P; Blanco I; Bujanda L; Fernández-Seara J
    Colorectal Dis; 2014 Aug; 16(8):O273-82. PubMed ID: 24456168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.
    Patel P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P; Ford AC
    Scand J Gastroenterol; 2015 Jul; 50(7):816-23. PubMed ID: 25636675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive values of colorectal cancer alarm symptoms in the general population: a nationwide cohort study.
    Rasmussen S; Haastrup PF; Balasubramaniam K; Elnegaard S; Christensen RD; Storsveen MM; Søndergaard J; Jarbøl DE
    Br J Cancer; 2019 Mar; 120(6):595-600. PubMed ID: 30792531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
    Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
    BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study.
    Herrero JM; Vega P; Salve M; Bujanda L; Cubiella J
    BMC Gastroenterol; 2018 Oct; 18(1):155. PubMed ID: 30359225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of alarm features for colorectal cancer: a meta-analysis.
    Frazzoni L; Laterza L; La Marca M; Zagari RM; Radaelli F; Hassan C; Repici A; Facciorusso A; Gkolfakis P; Spada C; Triantafyllou K; Bazzoli F; Dinis-Ribeiro M; Fuccio L
    Endoscopy; 2023 May; 55(5):458-468. PubMed ID: 36241197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower gastrointestinal symptoms and symptoms-based triaging systems are poor predictors of clinical significant disease on colonoscopy.
    Ismail MS; Aoko O; Sihag S; Connolly E; Omorogbe J; Semenov S; O'Morain N; O'Connor A; Breslin N; Ryan B; McNamara D
    BMJ Open Gastroenterol; 2020; 7(1):e000221. PubMed ID: 32337053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.
    Ford AC; Moayyedi P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Reinisch W
    Am J Gastroenterol; 2015 May; 110(5):716-24. PubMed ID: 25916225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon capsule endoscopy to screen for colorectal neoplasia in those with family histories of colorectal cancer.
    Parodi A; Vanbiervliet G; Hassan C; Hebuterne X; De Ceglie A; Filiberti RA; Spada C; Conio M
    Gastrointest Endosc; 2018 Mar; 87(3):695-704. PubMed ID: 28554656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Alarm symptoms' in patients with dyspepsia: a three-year prospective study from general practice.
    Meineche-Schmidt V; Jørgensen T
    Scand J Gastroenterol; 2002 Sep; 37(9):999-1007. PubMed ID: 12374244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible missed opportunities for diagnosing colorectal cancer in Dutch primary care: a multimethods approach.
    Brandenbarg D; Groenhof F; Siewers IM; van der Voort A; Walter FM; Berendsen AJ
    Br J Gen Pract; 2018 Jan; 68(666):e54-e62. PubMed ID: 29203683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct access colonoscopy: impact of intervention on time to colorectal cancer diagnosis and treatment in North West Tasmania.
    Allen P; Gately L; Banks P; Lee AYS; Hamilton G; Tan L; Sim S
    Intern Med J; 2017 Oct; 47(10):1129-1135. PubMed ID: 28585273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive values of upper gastrointestinal cancer alarm symptoms in the general population: a nationwide cohort study.
    Rasmussen S; Haastrup PF; Balasubramaniam K; Christensen RD; Søndergaard J; Jarbøl DE
    BMC Cancer; 2018 Apr; 18(1):440. PubMed ID: 29669540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features of bowel disease in patients aged <50 years in primary care: a large case-control study.
    Stapley SA; Rubin GP; Alsina D; Shephard EA; Rutter MD; Hamilton WT
    Br J Gen Pract; 2017 May; 67(658):e336-e344. PubMed ID: 28347985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
    Jobin G; Rodriguez-Suarez R; Betito K
    Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis.
    Ford AC; Veldhuyzen van Zanten SJ; Rodgers CC; Talley NJ; Vakil NB; Moayyedi P
    Gut; 2008 Nov; 57(11):1545-53. PubMed ID: 18676420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Colonoscopy Improves the Outcome of Patients With Symptomatic Colorectal Cancer.
    Alonso-Abreu I; Alarcón-Fernández O; Gimeno-García AZ; Romero-García R; Carrillo-Palau M; Nicolás-Pérez D; Jiménez A; Quintero E
    Dis Colon Rectum; 2017 Aug; 60(8):837-844. PubMed ID: 28682969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Cubiella J; Digby J; Rodríguez-Alonso L; Vega P; Salve M; Díaz-Ondina M; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Rodriguez-Moranta F; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Garayoa A; Ferrandez Á; Piñol V; Rodríguez-Alcalde D; Guardiola J; Steele RJ; Fraser CG;
    Int J Cancer; 2017 May; 140(10):2201-2211. PubMed ID: 28187494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.